In this study, we report that baseline DNA damage levels in human peripheral blood mononuclear cells (PBMCs), as measured by 53BP1+ foci quantification before irradiation, can predict direct and indirect ex vivo responses to simulated space radiation exposure, as well as toxicity outcomes from cancer radiotherapy treatments. Here, TP53BP1 is linked to cancer.